The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Amplification of wild-type RET and clinical response to selpercatinib for non–small-cell lung cancer (NSCLC).
 
Malini Marion Gandhi
No Relationships to Disclose
 
Biagio Ricciuti
Consulting or Advisory Role - Regeneron
 
Melissa Gildenberg
No Relationships to Disclose
 
Ankit Singh
No Relationships to Disclose
 
Yvonne Y. Li
No Relationships to Disclose
 
Andréanne Gagné
No Relationships to Disclose
 
Xinan Wang
No Relationships to Disclose
 
Kelly Fitzgerald
Research Funding - AstraZeneca (Inst)
 
Ayal Aizer
Consulting or Advisory Role - NH TherAGUIX; Novartis; seagen
Research Funding - NH TherAGUIX; Varian Medical Systems
 
Mizuki Nishino
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Toshiba (Inst)
 
Joao Victor Machado Alessi
No Relationships to Disclose
 
Federica Pecci
No Relationships to Disclose
 
Alessandro Di Federico
No Relationships to Disclose
 
Adam Fisch
No Relationships to Disclose
 
Valentina Nardi
Honoraria - Novartis
 
Lynette M. Sholl
Stock and Other Ownership Interests - Moderna Therapeutics (I)
Consulting or Advisory Role - AstraZeneca; Genentech (Inst); Lilly (Inst)
Research Funding - Bristol Myers Squibb (Inst); Roche/Genentech (Inst)
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; Archer; ARIAD; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; EMD Serono; Foundation Medicine; Genentech; Gilead Sciences; Gritstone Bio; Hengrui Therapeutics; Instil Bio; Janssen Oncology; Maverick Therapeutics; Merck; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Panasonic; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Julia K. Rotow
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech; Gritstone Bio; Guardant Health; Janssen; Lilly; Sanofi/Regeneron; Takeda
Travel, Accommodations, Expenses - AstraZeneca